Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $372.76 million as of April 28, 2026. Its market cap has decreased by -16.62% in one year.

Market Cap

372.76M

Enterprise Value

357.72M

Revenue

140.12M

Ranking

n/a

PE Ratio

9.72

Stock Price

$0.36

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 372.76M, an increase of 3,792.99%. That is a compound annual growth rate of 14.09%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	372.76M	-29.23%
Dec 31, 2025	526.74M	-8.88%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	422.78M
Glass House Brands	818.91M
Jushi Holdings	101.76M
Growth Stalk Holdings	89.32M
Sofgen Pharma	58.41M
Earth Science Tech	42.24M
Radnostix	40.78M
MariMed	31.51M

Market Cap Rankings